AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇰🇪
Doxorubicin Hydrochloride in Kenya
4 products registered with PPB — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ADRIB 50mg/25ml Solution For Infusion | H2026/CTD7059/13491 | M/S BETA DRUGS PVT. LTD | active | 6 Jul 2031 |
| ADRIB 50mg/25ml Solution For Infusion | H2022/CTD7059/13491 | M/S BETA DRUGS PVT. LTD | active | 22 Jun 2028 |
| I-DOX 20mg/10ml Injection | H2022/CTD7516/14117 | GETWELL PHARMACEUTICALS LTD | active | 11 Jan 2027 |
| I-DOX 50mg/25ml Injection | H2021/CTD7519/14138 | GETWELL PHARMACEUTICALS LTD | active | 20 Sept 2026 |
Doxorubicin Hydrochloride — PPB Registration Details
PPB (Kenya) has 4 registered products containing Doxorubicin Hydrochloride, of which 4 are currently active. Data is sourced directly from the official PPB drug register and refreshed daily.
Track Doxorubicin Hydrochloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.